As of 2026-01-29, the Relative Valuation of Biovaxys Technology Corp (BIOV.CN) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.22 CAD, the upside of Biovaxys Technology Corp based on Relative Valuation is -104.2%.
The range of the Relative Valuation is (0.01) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.01) - (0.01) | (0.01) |
| Upside | -103.3% - -105.0% | -104.2% |
| Date | P/E |
| 2026-01-27 | -1.20 |
| 2026-01-26 | -1.23 |
| 2026-01-23 | -1.25 |
| 2026-01-22 | -1.23 |
| 2026-01-21 | -1.28 |
| 2026-01-20 | -1.23 |
| 2026-01-19 | -1.34 |
| 2026-01-16 | -1.37 |
| 2026-01-15 | -1.45 |
| 2026-01-14 | -1.25 |
| 2026-01-13 | -1.20 |
| 2026-01-12 | -1.23 |
| 2026-01-09 | -1.37 |
| 2026-01-08 | -1.39 |
| 2026-01-07 | -1.28 |
| 2026-01-06 | -1.23 |
| 2026-01-05 | -1.31 |
| 2026-01-02 | -1.28 |
| 2025-12-31 | -1.23 |
| 2025-12-30 | -1.28 |
| 2025-12-29 | -1.23 |
| 2025-12-24 | -1.34 |
| 2025-12-23 | -1.39 |
| 2025-12-22 | -1.48 |
| 2025-12-19 | -1.39 |
| 2025-12-18 | -1.51 |
| 2025-12-17 | -1.34 |
| 2025-12-15 | -1.23 |
| 2025-12-12 | -1.23 |
| 2025-12-11 | -1.14 |
| 2025-12-10 | -1.06 |
| 2025-12-09 | -1.12 |
| 2025-12-05 | -1.06 |
| 2025-12-04 | -1.17 |
| 2025-12-03 | -1.25 |
| 2025-12-02 | -1.14 |
| 2025-12-01 | -1.09 |
| 2025-11-28 | -1.42 |
| 2025-11-27 | -1.48 |
| 2025-11-26 | -1.42 |
| 2025-11-25 | -1.23 |
| 2025-11-24 | -1.34 |
| 2025-11-21 | -1.53 |
| 2025-11-20 | -1.56 |
| 2025-11-18 | -1.56 |
| 2025-11-17 | -1.37 |
| 2025-11-14 | -1.45 |
| 2025-11-13 | -1.45 |
| 2025-11-12 | -1.28 |
| 2025-11-11 | -1.45 |